2025-2026 Regular Session • Michigan Legislature
SB0003
Legislative Summary
Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.
Demographic Impact
Overall analysis of equity impact
80% Positive
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/8/2025
Introduced By Senator Darrin Camilleri
Senate
1/8/2025
Referred To Committee On Finance, Insurance, And Consumer Protection
Senate
4/24/2025
Reported Favorably With Substitute (s-1) 4/23/2025
Senate
4/24/2025
Referred To Committee Of The Whole With Substitute (s-1)
Senate
4/24/2025
Rules Suspended For Immediate Consideration
Senate
4/24/2025
Reported By Committee Of The Whole Favorably With Substitute (s-1)
Senate
4/24/2025
Substitute (s-1) Concurred In
Senate
4/24/2025
Placed On Order Of Third Reading With Substitute (s-1)
Senate
4/24/2025
Rules Suspended
Senate
4/24/2025
Placed On Immediate Passage
Senate
4/24/2025
Amendment(s) Defeated
Senate
4/24/2025
Amendment(s) Adopted
Senate
4/24/2025
Passed Roll Call # 68 Yeas 20 Nays 15 Excused 1 Not Voting 1
Senate
4/24/2025
Received On 04/24/2025
House of Representatives
4/24/2025
Read A First Time
House of Representatives
4/24/2025
Referred To Committee On Government Operations
House of Representatives
Status Information
Current Status
Engrossed(4/24/2025)
Chamber
House of Representatives
Committee
Government Operations(House of Representatives)
